Zhejiang Huahai Pharmaceutical (SHA:600521) will redeem and delist its convertible corporate bonds on Nov. 2, according to a Friday filing with the Shanghai bourse.
The drug company will redeem the remaining unconverted bonds at 110 yuan apiece, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments